Company Search:
Advanced Search
Sponsored Links
Pharma Mar SA Company Snapshot
Pharma Mar SA operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pharma Mar SA with three other miscellaneous service companies in Europe: Innate Pharma S.A. of France (2018 sales of 79.89 million Euro [US$88.18 million] of which 100% was Licensing Revenue), AddLife AB of Sweden (2.48 billion Swedish Kronor [US$253.12 million] of which 58% was LabTech), and Basilea Pharmaceutica Limited which is based in Switzerland (106.09 million Swiss Francs [US$106.41 million] of which 100% was Pharmaceutical Products).

Sales Analysis. During the year ended December of 2018, sales at Pharma Mar SA were 162.59 million Euro (US$179.46 million). This is a decrease of 9.4% versus 2017, when the company's sales were 179.36 million Euro. Contributing to the drop in overall sales was the 25.3% decline in Consumer Chemical Sector, from 72.03 million Euro to 53.82 million Euro. . However, these declines were partially offset by the increase in sales of Biotech Sector (up 1.2% to 108.64 million Euro) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Pharma Mar SA
  Stock Performance Chart for Pharma Mar SA
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 1.90
(Figures in Euro)
1 Week 6.8%   13 Weeks -1.2%  
4 Weeks 7.8%   52 Weeks 47.0%  
Pharma Mar SA Key Data:
  Ticker: PHM Country: Spain
  Exchanges: MAD Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 162,587,000
(Year Ending Jan 2019).
Employees: 599
  Currency: Euro Market Cap: 419,538,428
  Fiscal Yr Ends: December Shares Outstanding: 221,275,542
  Share Type: ACCION Closely Held Shares: 46,997,097
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.